HomeCompareTIKRF vs GBDC

TIKRF vs GBDC: Dividend Comparison 2026

TIKRF yields 1818.18% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TIKRF wins by $4103414663.06M in total portfolio value
10 years
TIKRF
TIKRF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full TIKRF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — TIKRF vs GBDC

📍 TIKRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTIKRFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TIKRF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TIKRF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TIKRF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, TIKRF beats the other by $3,147,377,256,512,072.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TIKRF + GBDC for your $10,000?

TIKRF: 50%GBDC: 50%
100% GBDC50/50100% TIKRF
Portfolio after 10yr
$2051707352.31M
Annual income
$1,851,398,402,572,835.20/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

TIKRF
No analyst data
Altman Z
-46.7
Piotroski
0/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TIKRF buys
0
GBDC buys
0
No recent congressional trades found for TIKRF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTIKRFGBDC
Forward yield1818.18%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$4103414683.84M$20.78M
Annual income after 10y$3,702,796,788,756,407.00$16,389,263.41
Total dividends collected$4074760433.31M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: TIKRF vs GBDC ($10,000, DRIP)

YearTIKRF PortfolioTIKRF Income/yrGBDC PortfolioGBDC Income/yrGap
1← crossover$192,518$181,818.18$12,490$1,790.28+$180.0KTIKRF
2$3,477,331$3,271,336.99$16,522$3,157.73+$3.46MTIKRF
3$58,943,217$55,222,471.89$23,578$5,898.68+$58.92MTIKRF
4$937,891,469$874,822,227.57$37,115$11,886.75+$937.85MTIKRF
5$14,012,869,532$13,009,325,660.38$66,136$26,423.57+$14012.80MTIKRF
6$196,647,994,247$181,654,223,846.76$137,257$66,491.44+$196647.86MTIKRF
7$2,592,865,386,485$2,382,452,032,641.56$341,734$194,868.54+$2592865.04MTIKRF
8$32,132,661,421,271$29,358,295,457,731.54$1,050,788$685,133.02+$32132660.37MTIKRF
9$374,409,247,740,494$340,027,300,019,734.44$4,099,314$2,974,971.01+$374409243.64MTIKRF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$20,775,530$16,389,263.41+$4103414663.06MTIKRF

TIKRF vs GBDC: Complete Analysis 2026

TIKRFStock

Tikcro Technologies Ltd. focuses on development of biotechnology project in Israel. It offers anti-cytotoxic T-lymphocyte-associated protein 4 for cancer immune treatment. The company was formerly known as Tioga Technologies Ltd. and changed its name to Tikcro Technologies Ltd. in September 2003. Tikcro Technologies Ltd. was founded in 1999 and is headquartered in Hadera, Israel.

Full TIKRF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this TIKRF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TIKRF vs SCHDTIKRF vs JEPITIKRF vs OTIKRF vs KOTIKRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.